Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Tinostamustine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tinostamustine Included in GBM AGILE Trial for Glioblastoma
    Tinostamustine Included in GBM AGILE Trial for Glioblastoma

    17 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250917676784/en/Investigational-Drug-Tinostamustine-to-be-Included-in-GBM-AGILE-Clinical-Trial-for-Glioblastoma

    BUSINESSWIRE
    17 Sep 2025
    Share Share
    Purdue hires Ducharme as CSO to aid expansion beyond opioids
    Purdue hires Ducharme as CSO to aid expansion beyond opioids

    03 Jul 2019

    // Nick Paul FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/purdue-hires-ducharme-as-cso-to-aid-expansion-beyond-opioids?utm_source=internal&utm_medium=rss

    Nick Paul FIERCE BIOTECH
    03 Jul 2019
    Share Share
    Imbrium Announces USFDA Orphan Drug Designation for Tinostamustine
    Imbrium Announces USFDA Orphan Drug Designation for Tinostamustine

    28 Mar 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190328005218/en

    BUSINESSWIRE
    28 Mar 2019
    Share Share